Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Finance Home
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,405.60
+20.90
(+0.28%)
ASX 200
7,194.90
+21.60
(+0.30%)
AUD/USD
0.6580
-0.0022
(-0.34%)
OIL
71.26
+1.92
(+2.77%)
GOLD
2,020.80
-25.60
(-1.25%)
Bitcoin AUD
66,655.93
-312.26
(-0.47%)
FEELING THE PINCH?
Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now
Cellebrite DI Ltd. (CLBT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.55
+0.16
(+1.91%)
At close: 04:00PM EST
8.55
0.00
(0.00%)
After hours:
04:00PM EST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
306,115
270,651
246,246
194,913
171,854
Cost of revenue
50,446
50,746
42,557
37,879
35,823
Gross profit
255,669
219,905
203,689
157,034
136,031
Operating expenses
Research development
82,369
80,620
65,541
54,377
46,573
Selling general and administrative
145,388
138,241
124,326
91,166
90,228
Total operating expenses
227,757
218,861
189,867
147,816
137,551
Operating income or loss
27,912
1,044
13,822
9,218
-1,520
Total other income/expenses net
-
845
-171
-446
-188
Income before tax
-54,116
120,760
82,305
11,397
1,415
Income tax expense
5,259
-45
10,909
5,616
3,291
Income from continuing operations
-59,375
120,805
71,396
5,781
-1,876
Net income
-59,375
120,805
71,396
5,781
-1,876
Net income available to common shareholders
-64,069
120,805
71,396
-9,344
-10,039
Basic EPS
-0.20
0.64
0.49
-0.05
-0.05
Diluted EPS
-0.22
0.59
0.44
-0.05
-0.05
Basic average shares
185,704
182,693
144,002
187,169
187,169
Diluted average shares
191,835
195,394
161,539
187,169
187,169
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy choices
About our ads
© 2023 Yahoo. All rights reserved.